Male Infertility Market Key Players: Bayer Healthcare, Andrology Solutions, Aytu Bioscience, Inc., And Cadila Healthcare Ltd.

The global male infertility market size was valued at USD 4.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% from 2023 to 2030. Increasing infertility rates across the globe and the adoption of assisted reproductive technologies (ARTs) are expected to drive the market for male infertility in the forthcoming years. ARTs cover a wide spectrum of infertility treatments and offer solutions for males facing problems, such as low sperm count, abnormal sperm quality, and poor motility. Moreover, ARTs offer a high success rate as compared to medications. The market for male infertility is expected to witness significant growth in the future owing to technological advancements in the field of assisted reproductive technologies.

With the general acceptability and diagnostic techniques' ability to give an accurate analysis of sperm DNA integrity, DNA fragmentation technology is projected to grow steadily in the future. DNA fragmentation in sperm is one of the main reasons for male infertility. For diagnostic reasons, this technique is performed to diagnose male infertility. COVID-19 affected healthcare services severely. Only emergency medical procedures were allowed during the initial phase of the pandemic. The diagnostics, personal protection equipment, and critical medical supplies have seen increasing demand, while medical procedures have dropped by 50% to 60%, depending on the market.

The clinical disease generated by the SARS-CoV-2 virus, COVID-19, has been linked to a huge cytokine storm and organ system destruction. Despite the lack of evidence for SARS-CoV-2 virus detection in the testis, testicular injury and dysregulation of gonadotropins linked to inflammation have been documented in some studies. Furthermore, as a result of the pandemic's fast evolution, constantly updated medical therapies and governmental regulations that cause delays in care might affect fertility.

Gather more insights about the market drivers, restrains and growth of the Global Male Infertility market

An increase in the global prevalence of infertility is a significant clinical problem. Around 48 million couples suffer from infertility worldwide. Of all cases, about 20% to 30% of cases are due to male factor infertility. This may be due to one or a combination of factors, such as abnormal morphology, lower sperm concentration, and poor sperm motility. Hence, increasing male infertility and growing awareness regarding the same have further prompted the use of drugs, hormonal therapy, and ART. Alcohol intake, smoking, obesity, stress, and lifestyle changes are some of the major factors that can be attributed to infertility in males. According to the National Center for Health Statistics, the fertility rate in males below 30 years has decreased globally by 15% from 2006 to 2010.

Continuous efforts in R&D are carried out for a better understanding of the idiopathic world of infertility. Hence, companies are investing in the development of devices for identifying the root cause and targeted treatment. Furthermore, the development and commercialization of hormonal therapy are likely to drive the market for male infertility during the forecast period. Governments of various countries have taken initiatives to improve the reimbursement scenario for infertility-related treatments. In addition, improved safety of patient data due to standardization of regulations is expected to increase patient preference for infertility treatments.


Browse through Grand View Research's Healthcare IT Industry Research Reports.

  • Transitional Care Management Services Market - The global transitional care management services market was valued at USD 175.6 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 17.4% from 2022 to 2030.

 

  • Digital Health Market - The global digital health market size was valued at USD 211.0 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 18.6% from 2023 to 2030.

 

Male Infertility Market Segmentation

Grand View Research has segmented the global male infertility market based on test, treatment, and region:

Male Infertility Test Outlook (Revenue, USD Million, 2017 - 2030)

  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others

Male Infertility Treatment Outlook (Revenue, USD Million, 2017 - 2030)

  • Assisted Reproductive Technology and Varicocele Surgery
  • Medication

Male Infertility Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • May 2019: the National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA), Govt. of India, granted the Good Laboratory Practices Certification to Cadila Pharmaceuticals for its Dholka facility.
  • November 2017: Aytu BioScience received approval from the Australian Therapeutic Goods Administration (TGA) for the MiOXSYS system as an aid in the assessment of semen quality.

 

Key Companies profiled:

Some prominent players in the global male infertility market include:

  • Bayer Healthcare
  • Andrology Solutions
  • Aytu BioScience, Inc.
  • Cadila Healthcare Ltd.
  • Halotech DNA SL
  • EMD Sereno, Inc.
  • SCSA Diagnostics, Inc.
  • Intas Pharmaceuticals Ltd.

 

Order a free sample PDF of the Male Infertility Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

 

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more